Objective: Genital warts are caused by human papillomavirus (HPV), principally types 6 and
11, and are highly contagious. This study assessed treatment patterns and costs of …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …

Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …

Background: Data on the burden of genital warts in terms of treatment costs and detriment to
quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Genital warts, 90% of which are caused by human papillomavirus types 6 and 11, are a
significant problem in the UK. The cost of managing genital warts was previously estimated …

This article critically reviews both established and experimental treatment modalities for
anogenital (AG) warts. Efficacy, cost, safety, advantages and disadvantages of each therapy …